Buy Textbooks  |  Rent Textbooks  |  Sell Textbooks  |  eTextbooks
Help  |  Questions? 1-877-292-6442
Hello, Sign In
Your Account
0

Viral Vectors: Gene Therapy of the Central Nervous System - 2nd edition

Viral Vectors: Gene Therapy of the Central Nervous System (ISBN10: 0080454372; ISBN13: 9780080454375)
ISBN13: 978-0080454375
ISBN10: 0080454372

Summary: Few areas of biomedical research provide greater opportunities for radically new therapies for devastating diseases that have evaded treatment so far than gene therapy. This is particularly true for the brain and nervous system, where gene transfer has become a key technology for basic research and has recently been translated to human therapy in several landmark clinical trials.

Gene Therapy of the Central Nervous System: From Bench to Bedside represents ...show morethe first definitive volume on this subject. Edited by two pioneers of neurological gene therapy, this volume contains contributions by leaders who helped create this field and are expanding the promise of gene therapy for the future of basic and clinical neuroscience. Drawing upon this extensive collective experience, this book provides clear and informative reviews on a variety of subjects of interest to anyone exploring or using gene therapy for neurobiological applications in research and clinical praxis.

* Presents gene transfer technologies with particular emphases upon novel vehicles, immunological issues and the role of gene therapy in stem cells
* Discusses preclinical areas that are likely to translate into clinical studies in the near future, including epilepsy, pain and amyotrophic lateral sclerosis
* Includes "insider" information on technological and regulatory issues which can often limit effective translation of even the most promising idea into clinical use ...show less

Edition/Copyright: 2ND 05
Cover: Paperback
Publisher: Vitalsource Technologies, Inc.
Year Published: 2005
International: No

View eBook Requirements



List Price: $245.00
eTextbook $193.50
eTextbook
Save $51.50 (21%)
Close
Close
Close